NCT06631456

Brief Summary

Knee osteoarthritis can frequently occur with advancing age. In cases of pain that persists despite hot/cold applications, drug therapy and exercise, intra-articular injections are considered. In advanced-stage gonarthrosis, steroid injections may respond. However, in mild and moderate knee arthritis, regenerative methods come to the forefront because the joint cartilage is still partially/completely intact. PRP and ozone therapy are frequently applied intra-articular treatments. This study will compare the effects of both injection methods on clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

October 5, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

2 months

First QC Date

October 5, 2024

Last Update Submit

October 5, 2024

Conditions

Keywords

knee osteoarthritisplatelet rich plasmaozone therapy

Outcome Measures

Primary Outcomes (1)

  • Pain-Numerical Rating Scale

    Pain level will be evaluated with the Numerical Rating Scale. (minimum: 0, maximum: 10)

    From enrollment to the end of treatment at 3rd month

Secondary Outcomes (2)

  • Pain, stiffness and physical function-WOMAC

    From enrollment to the end of treatment at 3rd month

  • Quality of life-SF-12

    From enrollment to the end of treatment at 3rd month

Study Arms (2)

PRP group

Patients who received intra-articular PRP due to gonarthrosis

Other: PRP injection

Ozone group

Patients who received intra-articular ozone therapy due to gonarthrosis

Other: Ozone therapy

Interventions

A total of 3 doses of intra-articular PRP were applied to the symptomatic knees of the patients under ultrasound guidance, once a week.

PRP group

A total of 3 doses of intra-articular ozone therapy were applied to the symptomatic knees of the patients under ultrasound guidance, once a week.

Ozone group

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Stage 2-3 gonarthrosis according to KL who apply to our hospital\'s Physical Medicine and Rehabilitation out-patient clinic will be included.

You may qualify if:

  • years old, Stage 2-3 gonarthrosis according to KL
  • Voluntariness to participate in the study

You may not qualify if:

  • Cognitive dysfunction
  • General medical condition is not suitable for injections and evaluations
  • History of knee injections in the last 3 months
  • History of previous knee surgery
  • Bleeding disorders or those taking medications that may cause bleeding disorders after injections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Şişli Hamidiye Etfal Training and Research Hospital, İstanbul

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Banu Kuran, Professor

    Şişli Hamidiye Etfal Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

October 5, 2024

First Posted

October 8, 2024

Study Start

August 1, 2024

Primary Completion

September 30, 2024

Study Completion

October 1, 2024

Last Updated

October 8, 2024

Record last verified: 2024-10

Locations